Neuphoria Therapeutics (NEUP)

Profile

Full Name

Neuphoria Therapeutics Inc.

Ticker Symbol

NEUP

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 16, 2021

Indexes

Not included

Website

http://www.neuphoriatx.com

Employees

8

Key Details

Price

$5.14(+0.57%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.12(+50.00% YoY)

PE ratio

-

Next earnings date

Nov 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.14
NEUP price is $5.14

30-Day Relative Volume

0.14
NEUP 30-day relative volume is 0.14

Price Performance

Price Most recent change

+0.57%
NEUP price was up +0.57% on Apr 17, 2025

Price YTD change

+49.83%
NEUP price is up +49.83% since January 1st

Price 1-year change

-55.34%
NEUP price is down -55.34% year-on-year

Price 3-year change

-95.49%
NEUP price is down -95.49% over the past 3 years

Price Range

Price All-time high

$264.00
NEUP price is currently -98.05% below its historical high of $264.00

Price 3-year low

$2.12
NEUP price is currently +141.95% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$9.03M
NEUP market capitalization is $9.03 million

Market cap 3-year change

-99.99%
NEUP market capitalization is down -99.99% over the past 3 years

Market cap All-time high

$210.64B
NEUP market capitalization is currently -100.00% below its historical high of $210.64 billion

Market cap sector rank

18.93%
NEUP market capitalization is higher than 18.93% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-99.91%
NEUP shares outstanding is down -99.91% year-on-year

Shares Outstanding 3-Year Change

-99.87%
NEUP shares outstanding is down -99.87% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.51
NEUP beta is 1.51

200-day SMA

$5.36
NEUP price is currently -4.12% below its 200-day simple moving average

50-day SMA

$5.12
NEUP price is currently +0.31% above its 50-day simple moving average

RSI

49.71
NEUP 14-day relative strength index is 49.71

Volume

0.14
NEUP 30-day relative volume is 0.14

ATR

$0.36
NEUP average true range is $0.36

10-day Historical Volatility

76.77%
NEUP 10-day historical volatility is 76.77%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
NEUP annual revenue value is unknown

Revenue Analysts estimate

$24.64M
NEUP annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
NEUP annual revenue 1-year change is unknown

Revenue Sector rank

-
NEUP annual revenue is unknown

EPS

EPS

-$0.12
NEUP annual earnings per share is -$0.12

EPS Analysts estimate

-$1.85
NEUP annual earnings per share is currently -93.51% lower than the consensus analysts' forecast

EPS 1-year change

+50%
NEUP annual earnings per share is up +50% year-on-year

EPS Sector rank

-
NEUP annual earnings per share is unknown

Profit

Gross profit

-
NEUP annual gross profit value is unknown

Gross margin

-
NEUP annual gross profit margin value is unknown

Operating profit

-$17.80M
NEUP annual operating income is -$17.80 million

Operating margin

-
NEUP annual operating profit margin value is unknown

Net income

-$15.49M
NEUP annual net profit is -$15.49 million

Net margin

-
NEUP annual net profit margin value is unknown

Expenses

Total expenses

$17.80M
NEUP annual total expenses is $17.80 million

Operating expenses

$17.80M
NEUP annual total operating expenses is $17.80 million

Cost of goods sold

-
NEUP annual cost of goods sold value is unknown

Selling, general & administrative expenses

$8.47M
NEUP annual SGA is $8.47 million

Depreciation and amortization

$663.00K
NEUP annual depreciation & amortization is $663.00 thousand

Interest expense

-
NEUP annual interest expense value is unknown

Income tax

-$87.30K
NEUP annual income tax is -$87.30 thousand

EBIT & EBITDA

EBIT

-$17.80M
NEUP annual earnings before interest & taxes is -$17.80 million

EBITDA

-$17.13M
NEUP annual EBITDA is -$17.13 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$27.65M
NEUP annual total assets is $27.65 million

Non current assets

$14.46M
NEUP annual long term assets is $14.46 million

Current assets

$13.19M
NEUP annual total current assets is $13.19 million

Cash and cash equivalents

$12.61M
NEUP annual cash & cash equivalents is $12.61 million

Accounts receivable

-
NEUP annual accounts receivable value is unknown

Inventory

-
NEUP annual inventory value is unknown

Liabilities

Total liabilities

$10.16M
NEUP annual total liabilities is $10.16 million

Long term liabilities

$6.33M
NEUP annual total long term liabilities is $6.33 million

Current liabilities

$3.83M
NEUP annual total current liabilities is $3.83 million

Accounts payable

$2.24M
NEUP annual accounts payable is $2.24 million

Debt

Total debt

$272.70K
NEUP annual total debt is $272.70 thousand

Total debt 1-year change

-29.52%
NEUP annual total debt is down -29.52% year-on-year

Long term debt

$117.60K
NEUP annual long term debt is $117.60 thousand

Short term debt

$155.10K
NEUP annual short term debt is $155.10 thousand

Equity & Capital

Shareholders equity

$17.49M
NEUP annual stockholders equity is $17.49 million

Book value

$17.49M
NEUP annual book value is $17.49 million

Retained earnings

-$177.98M
NEUP annual retained earnings is -$177.98 million

Working capital

$9.36M
NEUP annual working capital is $9.36 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$14.68M
NEUP annual cash flow from operations is -$14.68 million

Cash from operations 1-year change

-0.29%
NEUP annual cash flow from operations is down -0.29% year-on-year

Cash from investing

-
NEUP annual cash flow from investing activities value is unknown

Cash from investing 1-year change

-
NEUP annual cash flow from investing activities 1-year change is unknown

Cash from financing

$15.11M
NEUP annual cash flow from financing activities is $15.11 million

Cash from financing 1-year change

+291.57%
NEUP annual cash flow from financing activities is up +291.57% year-on-year

CAPEX

CAPEX

-
NEUP annual capital expenditures value is unknown

CAPEX 1-year change

-
NEUP annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$14.68M
NEUP annual free cash flow is -$14.68 million

Free cash flow 1-year change

-0.29%
NEUP annual free cash flow is down -0.29% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
NEUP annual gross profit margin value is unknown

Operating margin

-
NEUP annual operating profit margin value is unknown

Net margin

-
NEUP annual net profit margin value is unknown

ROA & ROE

ROA

-56.03%
NEUP annual return on assets is -56.03%

ROE

-88.58%
NEUP annual return on equity is -88.58%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NEUP price to earnings ratio value is unknown

PE ratio Sector rank

-
NEUP price to earnings ratio is unknown

PB Ratio

PB ratio

0.66
NEUP price to book ratio is 0.66

PB ratio Sector rank

35.12%
NEUP price to book ratio is higher than 35.12% of companies in Healthcare sector

PS Ratio

PS ratio

13.62
NEUP price to sales ratio is 13.62

PS ratio Sector rank

83.95%
NEUP price to sales ratio is higher than 83.95% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.88M
NEUP enterprise value is $4.88 million

Enterprise value Sector rank

19.67%
NEUP enterprise value is higher than 19.67% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.74
NEUP EV/EBITDA is -0.74

EV/EBITDA Sector rank

47.26%
NEUP EV/EBITDA is higher than 47.26% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.45
NEUP annual current ratio is 3.45

Quick ratio

-
NEUP annual quick ratio value is unknown

Leverage

Debt to equity

0.02
NEUP annual debt to equity ratio is 0.02

Interest coverage ratio

-
NEUP annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
NEUP piotroski f-score value is unknown

Altman Z-Score

-
NEUP altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Feb 4, 25 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

NURO logo
NeuroMetrix (NURO)
COSCIENS Biopharma (CSCI)
HCTI logo
Healthcare Triangle (HCTI)
BCDA logo
BioCardia (BCDA)
BMRA logo
Biomerica (BMRA)
IBIO logo
iBio (IBIO)
BIAF logo
bioAffinity Technologies (BIAF)
GOVX logo
GeoVax Labs (GOVX)
Gelteq Limited (GELS)
  • What is the ticker symbol for Neuphoria Therapeutics?
  • Does Neuphoria Therapeutics pay dividends?
  • What sector is Neuphoria Therapeutics in?
  • What industry is Neuphoria Therapeutics in?
  • What country is Neuphoria Therapeutics based in?
  • When did Neuphoria Therapeutics go public?
  • Is Neuphoria Therapeutics in the S&P 500?
  • Is Neuphoria Therapeutics in the NASDAQ 100?
  • Is Neuphoria Therapeutics in the Dow Jones?
  • When was Neuphoria Therapeutics's last earnings report?
  • When does Neuphoria Therapeutics report earnings?
  • Should I buy Neuphoria Therapeutics stock now?

What is the ticker symbol for Neuphoria Therapeutics?

The ticker symbol for Neuphoria Therapeutics is NASDAQ:NEUP

Does Neuphoria Therapeutics pay dividends?

No, Neuphoria Therapeutics does not pay dividends

What sector is Neuphoria Therapeutics in?

Neuphoria Therapeutics is in the Healthcare sector

What industry is Neuphoria Therapeutics in?

Neuphoria Therapeutics is in the Biotechnology industry

What country is Neuphoria Therapeutics based in?

Neuphoria Therapeutics is headquartered in United States

When did Neuphoria Therapeutics go public?

Neuphoria Therapeutics's initial public offering (IPO) was on December 16, 2021

Is Neuphoria Therapeutics in the S&P 500?

No, Neuphoria Therapeutics is not included in the S&P 500 index

Is Neuphoria Therapeutics in the NASDAQ 100?

No, Neuphoria Therapeutics is not included in the NASDAQ 100 index

Is Neuphoria Therapeutics in the Dow Jones?

No, Neuphoria Therapeutics is not included in the Dow Jones index

When was Neuphoria Therapeutics's last earnings report?

Neuphoria Therapeutics's most recent earnings report was on Nov 14, 2024

When does Neuphoria Therapeutics report earnings?

The next expected earnings date for Neuphoria Therapeutics is Nov 14, 2025

Should I buy Neuphoria Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page